Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HIST1H2AL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARID3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DACH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCR10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MARVELD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STXBP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC27A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UAP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC11C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VRK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEMA7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4657 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAV1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on